European Companies Search Engine
Santen Pharmaceutical Co. Ltd., Osaka, Japan
If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.
The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .
Add to dossier (if available):
Name
Identification
Address
Corporate purpose
Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally. It offers various pharmaceutical products to treat glaucoma and ocular hypertension, such as DE-111, which is in Phase III clinical trial; DE-117 in Japan; DE-126 that is in Phase IIb clinical trial; DE-128 in Europe, as well as is in Phase II/III clinical trial in the United States; and DE-130A that is in Phase III clinical trial … Show more
History
Network
Annual report
Publications
Mentions
The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.
The visualizations for "Santen Pharmaceutical Co. Ltd., Osaka, Japan"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.